|
|
Although biotechnology companies face many of the same challenges as pharmaceutical manufacturers, there are also unique issues confronting this industry. Because many biotech firms are smaller, start-up companies, resources for marketing and selling new products are often limited compared to larger pharmaceutical manufacturers. In addition, fewer large molecule drugs are reimbursable; thus, creating a significant barrier to converting patients and care providers. An ever-present issue is the ethical scrutiny large molecule manufacturers face regarding the development and testing of personalized medicines. Burke can help you talk to care providers, managed care professionals and healthcare consumers and turn those conversations into meaningful marketing strategies, based on the optimal allocation of your available resources.
|